Nanolive hosts this event on “Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules”.
In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity assays from industry-leading biopharma companies to test toxicity, selectivity, uptake and expression of different targeted therapies.
- Immune cell therapeutics:
- Bispecific antibody screening in a T cell-target cell co-culture (Light Chain Bioscience)
- Drug selectivity and cytotoxicity:
- mRNA expression and cytotoxicity (TRON)
- Drug selectivity in co-cultures: senolytics (dsm-firmenich)
- Measuring particle uptake (bit.bio)
This webinar lasts 20 to 25 minutes.
Read our latest news
Nanolive launches the Smart Mitochondrial Assay LIVE
Nanolive launches another ground-breaking tool in cell analysis: the Smart Mitochondrial AssayLIVE, the world’s first fully automated solution for noninvasive, quantitative assessment of mitochondrial dynamics. Created to accelerate drug discovery, the Smart...
Newsletter February: Unlocking the power of Nanolive’s holotomography
Welcome to the February edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Newsletter January: Breaking records and paving the way for future discoveries in car-t, mitochondria & lipid droplets research
Welcome to the January edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...